207 related articles for article (PubMed ID: 23862745)
21. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
22. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
23. MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
Song Y; Xu X; Wang N; Zhang T; Hu C
J Clin Lab Anal; 2022 Apr; 36(4):e24254. PubMed ID: 35212031
[TBL] [Abstract][Full Text] [Related]
24. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
25. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
26. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
[TBL] [Abstract][Full Text] [Related]
27. SELDI-TOF-MS proteomics of breast cancer.
Clarke CH; Buckley JA; Fung ET
Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
[TBL] [Abstract][Full Text] [Related]
28. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
Zhang H; Feng J; Chang XH; Li ZX; Wu XY; Cui H
Chin Med J (Engl); 2009 Feb; 122(4):373-6. PubMed ID: 19302738
[TBL] [Abstract][Full Text] [Related]
29. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
30. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
Seibert V; Ebert MP; Buschmann T
Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
[TBL] [Abstract][Full Text] [Related]
31. SELDI-TOF proteomic analysis and cancer detection.
Henderson NA; Steele RJ
Surgeon; 2005 Dec; 3(6):383-90, 422. PubMed ID: 16353858
[TBL] [Abstract][Full Text] [Related]
32. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
Skytt A; Thysell E; Stattin P; Stenman UH; Antti H; Wikström P
Int J Cancer; 2007 Aug; 121(3):615-20. PubMed ID: 17410539
[TBL] [Abstract][Full Text] [Related]
33. Detection and significance of serum protein markers of small-cell lung cancer.
Han M; Liu Q; Yu J; Zheng S
J Clin Lab Anal; 2008; 22(2):131-7. PubMed ID: 18348318
[TBL] [Abstract][Full Text] [Related]
34. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.
Ciavarella D; Mastrovincenzo M; D'Onofrio V; Chimenti C; Parziale V; Barbato E; Lo Muzio L
Prog Orthod; 2011 Nov; 12(2):126-31. PubMed ID: 22074837
[TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of resectable non-small cell lung cancer: post-resection serum samples may be useful in identifying potential markers.
Rathinam S; Ward DG; James ND; Rajesh PB
Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):3-6. PubMed ID: 21525028
[TBL] [Abstract][Full Text] [Related]
36. Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis.
Wada-Isoe K; Michio K; Imamura K; Nakaso K; Kusumi M; Kowa H; Nakashima K
J Neural Transm (Vienna); 2007; 114(12):1579-83. PubMed ID: 17690946
[TBL] [Abstract][Full Text] [Related]
37. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry.
Merchant M; Weinberger SR
Electrophoresis; 2000 Apr; 21(6):1164-77. PubMed ID: 10786889
[TBL] [Abstract][Full Text] [Related]
38. Detection of serum protein biomarkers by surface enhanced laser desorption/ionization in patients with adenocarcinoma of the lung.
Jiang M; Gu G; Ni B; Wang W; Shi J; Liao P; Hu H
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e7-12. PubMed ID: 23441957
[TBL] [Abstract][Full Text] [Related]
39. Proteiomic patterns for endometrial cancer using SELDI-TOF-MS.
Zhu LR; Zhang WY; Yu L; Zheng YH; Hu J; Liao QP
J Zhejiang Univ Sci B; 2008 Apr; 9(4):286-90. PubMed ID: 18381802
[TBL] [Abstract][Full Text] [Related]
40. Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum.
Albrethsen J; Bøgebo R; Olsen J; Raskov H; Gammeltoft S
Clin Chem Lab Med; 2006; 44(10):1243-52. PubMed ID: 17032137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
